Sinocelltech
Sinocelltech is a China-based biotechnology company running 8 late-stage cancer trials of SCTB41, SCTB35 and SCTC21C in multiple myeloma, non-small-cell lung cancer and diffuse large B-cell lymphoma.
Overview
Sinocelltech, based in Beijing, China, is a biotechnology company. Sinocelltech is a biopharmaceutical company that researches, manufactures and commercialises monoclonal antibodies, recombinant proteins and vaccines. On ClinicalTrials.gov it is the lead sponsor of 8 recruiting or active phase 2 and phase 3 interventional cancer trials (6 in phase 3), testing SCTB41, SCTB35, SCTC21C, SCTB39-1 and SCTB14 in multiple myeloma, non-small-cell lung cancer, diffuse large B-cell lymphoma and follicular lymphoma. The largest, NCT06041061 (A Study to Evaluate the Efficacy, Safety, and Immunogenicity of SCT1000 in Healthy Women Aged 18-45 Years), plans to enrol 18000 participants (actual). Sponsor and trial facts are from the ClinicalTrials.gov registry, checked on 2026-09-11; company facts are from the official website.
Scorecard
All companies- phase 3 +12
- modalities +2
SCTB41 is an experimental investigational agent whose form is not stated in the registry from Sinocelltech in phase 3 trials for non-small-cell lung cancer, with its target not yet stated publicly.
SCTB35 is an experimental investigational agent whose form is not stated in the registry from Sinocelltech in phase 3 trials for diffuse large B-cell lymphoma and follicular lymphoma, with its target not yet stated publicly.
SCTC21C is an experimental investigational agent whose form is not stated in the registry from Sinocelltech in phase 3 trials for multiple myeloma, with its target not yet stated publicly.
SCTB14 is an experimental investigational agent whose form is not stated in the registry from Sinocelltech in phase 3 trials for non-small-cell lung cancer, with its target not yet stated publicly.
Similar pages
not linked directly; found by shared links- CompanyHaihe Biopharma
Shares Follicular lymphoma, Non-small-cell lung cancer and the tag ctgov-sponsor.
- CompanyCelltrion
Shares Multiple myeloma, Non-small-cell lung cancer and the tag ctgov-sponsor.
- CompanyNanjing Leads Biolabs
Shares Multiple myeloma, Non-small-cell lung cancer and the tag ctgov-sponsor.
- CompanyChongqing Precision Biotech
Shares Multiple myeloma and the tag ctgov-sponsor.
- CompanyEvopoint Biosciences
Shares Follicular lymphoma and the tag ctgov-sponsor.
- CompanyShanghai AbelZeta
Shares Multiple myeloma and the tag ctgov-sponsor.
- CompanyRanok Therapeutics (Hangzhou)
Shares Diffuse large B-cell lymphoma and the tag ctgov-sponsor.
- CompanyAvistone Biotechnology
Shares Non-small-cell lung cancer and the tag ctgov-sponsor.